Charles Schwab’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-32,553
| Closed | -$16K | – | 3533 |
|
|
2020
Q4 | $16K | Hold |
32,553
| – | – | ﹤0.01% | 3383 |
|
|
2020
Q3 | $18K | Hold |
32,553
| – | – | ﹤0.01% | 3319 |
|
|
2020
Q2 | $23K | Sell |
32,553
-176,810
| -84% | -$142K | ﹤0.01% | 3288 |
|
|
2020
Q1 | $177K | Buy |
209,363
+4,952
| +2% | +$7.08K | ﹤0.01% | 3031 |
|
|
2019
Q4 | $336K | Buy |
204,411
+2,239
| +1% | +$3.36K | ﹤0.01% | 2951 |
|
|
2019
Q3 | $225K | Hold |
202,172
| – | – | ﹤0.01% | 3027 |
|
|
2019
Q2 | $251K | Buy |
202,172
+68,619
| +51% | +$87.4K | ﹤0.01% | 3059 |
|
|
2019
Q1 | $193K | Buy |
133,553
+32,553
| +32% | +$48.3K | ﹤0.01% | 3028 |
|
|
2018
Q4 | $120K | Hold |
101,000
| – | – | ﹤0.01% | 3079 |
|
|
2018
Q3 | $137K | Hold |
101,000
| – | – | ﹤0.01% | 3105 |
|
|
2018
Q2 | $232K | Hold |
101,000
| – | – | ﹤0.01% | 3044 |
|
|
2018
Q1 | $153K | Buy |
+101,000
| New | +$118K | ﹤0.01% | 3017 |
|
|
2017
Q4 | – | Sell |
-48,100
| Closed | -$56K | – | 3065 |
|
|
2017
Q3 | $56K | Sell |
48,100
-57,332
| -54% | -$72.3K | ﹤0.01% | 3067 |
|
|
2017
Q2 | $184K | Buy |
105,432
+646
| +0.6% | +$1.37K | ﹤0.01% | 3045 |
|
|
2017
Q1 | $277K | Buy |
104,786
+5,814
| +6% | +$20.9K | ﹤0.01% | 2845 |
|
|
2016
Q4 | $421K | Buy |
98,972
+5,236
| +6% | +$17.3K | ﹤0.01% | 2715 |
|
|
2016
Q3 | $251K | Buy |
93,736
+45,636
| +95% | +$105K | ﹤0.01% | 2841 |
|
|
2016
Q2 | $86K | Sell |
48,100
-29,589
| -38% | -$60.4K | ﹤0.01% | 3066 |
|
|
2016
Q1 | $181K | Buy |
77,689
+1,224
| +2% | +$2.77K | ﹤0.01% | 2919 |
|
|
2015
Q4 | $266K | Buy |
76,465
+1,560
| +2% | +$7.47K | ﹤0.01% | 2900 |
|
|
2015
Q3 | $460K | Buy |
74,905
+48,105
| +179% | +$326K | ﹤0.01% | 2658 |
|
|
2015
Q2 | $177K | Hold |
26,800
| – | – | ﹤0.01% | 2998 |
|
|
2015
Q1 | $191K | Buy |
+26,800
| New | +$202K | ﹤0.01% | 2959 |
|
Other funds holding GEN
IC
TRCT
Charles Schwab's GEN Position: Q1 2021 in Review
Charles Schwab sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 32,553 shares — an estimated $16K sold.
Charles Schwab first reported a position in GEN in Q1 2015 and held it in 23 quarters. The position peaked at $460K in Q3 2015. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.
- Charles Schwab reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
- Charles Schwab sold 32,553 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $16K.
- Charles Schwab first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 23 quarters.
- Charles Schwab's Genesis Healthcare, Inc. position peaked at $460K in Q3 2015.
- 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.